Skip to main content

EvaMist FDA Approval History

FDA Approved: Yes (First approved July 27, 2007)
Brand name: EvaMist
Generic name: estradiol
Dosage form: Transdermal Spray
Company: VIVUS, Inc.
Treatment for: Postmenopausal Symptoms

EvaMist is an estradiol transdermal spray administered once daily for the treatment of vasomotor symptoms (hot flashes) associated with menopause.

Development timeline for EvaMist

Jul 30, 2007Approval KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist
Dec 12, 2006VIVUS Announces FDA Acceptance of EvaMist NDA Submission
Oct  2, 2006VIVUS Submits New Drug Application With U.S. Food and Drug Administration for EvaMist

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.